Grant: Discovery Grants Program - Individual
Université de Montréal
$24,000.00
In vitro-in vivo extrapolations and physiologically-based pharmacokinetic modeling: Predicting permeability, clearance, metabolic interactions and interindivual variability from in vitro data
FY 2018-19
Summary
In vitro data of different processes of toxicokinetics related to absorption, distribution metabolism and excretion can be generated very rapidly and in large quantity (i.e., high throughput). Currently there is a lot of enthusiasm towards the use of such data towards quantitative predictions of the in vivo toxicokinetics of xenobiotics. Although there are still some hurdles, there have been some scientific advancements/breakthroughs related to extrapolating in vitro data to the in vivo situation especially related to the prediction of hepatic clearance from in vitro data. But there is still quite some room for improvement and validation. We still do not know how to adequately deal with chemicals binding to multiple plasma proteins that include albumin? How should we deal with these chemicals? Are these newly developed clearance models also adequate for in vitro-in vivo extrapolation (IVIVE) of chemical-chemical interactions at the level of metabolism and protein binding displacements? Can they be used to predict variability in clearance in the population. Also, one of the current greatest difficulties in qunatitatively predicting xenobiotic in vivo toxicokinetics is the distribution of compounds that have low membrane permeability, i.e., diffusion limited tissue distribution. There is simply no approach existing to predict the in vivo permeability in tissues when it is the rate limiting factor of tissue uptake. The proposed research program therefore to to increase our ability to predict in vivo tissue dosimetry and toxicokinetics from in vitro data using PBPK modeling. The program will be divided in 2 specific objectives: 1) to develop a physiologically based approach to enable IVIVE of membrane permeability for a better predictability of diffusion limited tissue uptake; and 2) to refine IVIVE clearance models for compounds alone and for mixtures to ameliorate in vivo predictions and estimate variability in a population. On the long-term, our goal is to have a validated PBPK model framework that will allow IVIVE of different toxicokinetic determinants and to increase confidence in the use of in vitro data for the prediction of in vivo toxicokinetics. By acquiring clearance and permeability data from in vitro and in vivo experimental systems, we will derive mechanistic relationship to enhance and/or enhance IVIVE approaches in toxicokinetics and hence refine PBPK modeling for predictive toxicology. The success of this research program will inevitably decrease our need to use live animals in toxicokinetic data and increase our ability to predict in vivo toxicokinetics from simple in vitro experiments that can be generated in highthrouput. This will facilitate and accelerate decision making in risk assessment of environmental contaminants as well as in drug development.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-05577
Name nom
Haddad, Sami
Department département
Santé environnementale et santé au travail
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2015
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
405
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Modelling and mathematical simulation of natural processes
Area of application fr
Modélisation et simulation mathématique des processus naturels
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Partie
4
Nb partie
5
Application title
In vitro-in vivo extrapolations and physiologically-based pharmacokinetic modeling: Predicting permeability, clearance, metabolic interactions and interindivual variability from in vitro data
Keyword
NSERC
Application summary
In vitro data of different processes of toxicokinetics related to absorption, distribution metabolism and excretion can be generated very rapidly and in large quantity (i.e., high throughput). Currently there is a lot of enthusiasm towards the use of such data towards quantitative predictions of the in vivo toxicokinetics of xenobiotics. Although there are still some hurdles, there have been some scientific advancements/breakthroughs related to extrapolating in vitro data to the in vivo situation especially related to the prediction of hepatic clearance from in vitro data. But there is still quite some room for improvement and validation. We still do not know how to adequately deal with chemicals binding to multiple plasma proteins that include albumin? How should we deal with these chemicals? Are these newly developed clearance models also adequate for in vitro-in vivo extrapolation (IVIVE) of chemical-chemical interactions at the level of metabolism and protein binding displacements? Can they be used to predict variability in clearance in the population. Also, one of the current greatest difficulties in qunatitatively predicting xenobiotic in vivo toxicokinetics is the distribution of compounds that have low membrane permeability, i.e., diffusion limited tissue distribution. There is simply no approach existing to predict the in vivo permeability in tissues when it is the rate limiting factor of tissue uptake. The proposed research program therefore to to increase our ability to predict in vivo tissue dosimetry and toxicokinetics from in vitro data using PBPK modeling. The program will be divided in 2 specific objectives: 1) to develop a physiologically based approach to enable IVIVE of membrane permeability for a better predictability of diffusion limited tissue uptake; and 2) to refine IVIVE clearance models for compounds alone and for mixtures to ameliorate in vivo predictions and estimate variability in a population. On the long-term, our goal is to have a validated PBPK model framework that will allow IVIVE of different toxicokinetic determinants and to increase confidence in the use of in vitro data for the prediction of in vivo toxicokinetics. By acquiring clearance and permeability data from in vitro and in vivo experimental systems, we will derive mechanistic relationship to enhance and/or enhance IVIVE approaches in toxicokinetics and hence refine PBPK modeling for predictive toxicology. The success of this research program will inevitably decrease our need to use live animals in toxicokinetic data and increase our ability to predict in vivo toxicokinetics from simple in vitro experiments that can be generated in highthrouput. This will facilitate and accelerate decision making in risk assessment of environmental contaminants as well as in drug development.